CollPlant Biotechnologies (CLGN) Invested Capital (2017 - 2026)

CollPlant Biotechnologies has reported Invested Capital for 10 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 60.59% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (down 60.59% YoY), and the FY2025 full-year result was $6.1 million, down 54.84% from the prior year.
• Invested Capital for Q1 2026 stood at $4.9 million, down from $6.1 million in the prior quarter.
• The five-year high for Invested Capital was $43.2 million in Q1 2022, with the low at $4.9 million in Q1 2026.
• Historically, Invested Capital has averaged $23.4 million across 5 years, with a median of $24.4 million in 2024.
• Annual changes were most pronounced in 2023 — Invested Capital slipped 8.77% — and 2026, when it tumbled 60.59%.
• CollPlant Biotechnologies' Invested Capital stood at $32.3 million in 2022, then slipped by 12.21% to $28.3 million in 2023, then sank by 52.49% to $13.5 million in 2024, then sank by 54.84% to $6.1 million in 2025, then slipped by 19.65% to $4.9 million in 2026.
• The last three Invested Capital figures came in at $4.9 million (Q1 2026), $6.1 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.